ReviewF1000prime reports2014
A CRISPR method for genome engineering.
Review in F1000prime reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- CRISPR-Cpf1 system and its applications in animal genome editing.Molecular genetics and genomics : MGG · 2024Review
- Portable CRISPR-Cas9Applied and environmental microbiology · 2021Article
- Can Designer Indels Be Tailored by Gene Editing?: Can Indels Be Customized?BioEssays : news and reviews in molecular, cellular and developmental biology · 2019Article
- Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.Molecular cell · 2019Article
- Article
- Oral Administration of RecombinantFrontiers in microbiology · 2018Article
- Structural insights into DNA cleavage activation of CRISPR-Cas9 system.Nature communications · 2017Article
- Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System.Molecular pharmaceutics · 2016Article
- Salient Features of Endonuclease Platforms for Therapeutic Genome Editing.Molecular therapy : the journal of the American Society of Gene Therapy · 2016Review
- Proliferation control in neural stem and progenitor cells.Nature reviews. Neuroscience · 2015Review
- The history and market impact of CRISPR RNA-guided nucleases.Current opinion in virology · 2015Article
- Higher-order genetic interactions and their contribution to complex traits.Trends in genetics : TIG · 2015Review
- The Addgene repository: an international nonprofit plasmid and data resource.Nucleic acids research · 2015Article
- Addgene: making materials sharing "science as usual".PLoS biology · 2014Article
- A CRISPR view of development.Genes & development · 2014Review
- Unravelling the structural and mechanistic basis of CRISPR-Cas systems.Nature reviews. Microbiology · 2014Review
- Functional toxicology: tools to advance the future of toxicity testing.Frontiers in genetics · 2014Review
- Germline modification of domestic animals.Animal reproductionArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Clustered regularly interspaced short palindromic repeat (CRISPR) RNA-guided adaptive immune systems that protect bacteria and archaea from infection by viruses are now being routinely repurposed for genome engineering in a wide variety of cell types and multicellular organisms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.